VOYA Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Buy
42,175
+5,235
+14% +$225K ﹤0.01% 1229
2026
Q1
$1.36M Buy
36,940
+2,000
+6% +$94.8K ﹤0.01% 1350
2025
Q4
$1.78M Buy
34,940
+5,645
+19% +$289K ﹤0.01% 1260
2025
Q3
$1.63M Buy
29,295
+1,930
+7% +$113K ﹤0.01% 1314
2025
Q2
$1.89M Sell
27,365
-21,810
-44% -$1.48M ﹤0.01% 1328
2025
Q1
$3.41M Sell
49,175
-70
-0.1% -$5.78K ﹤0.01% 1098
2024
Q4
$4.24M Sell
49,245
-31,696
-39% -$3.43M ﹤0.01% 1038
2024
Q3
$9.64M Sell
80,941
-77,417
-49% -$10.3M 0.01% 781
2024
Q2
$22.6M Buy
158,358
+30,998
+24% +$4.11M 0.02% 505
2024
Q1
$16.4M Buy
127,360
+67,920
+114% +$8.09M 0.02% 600
2023
Q4
$6.15M Sell
59,440
-12,100
-17% -$1.2M 0.01% 916
2023
Q3
$6.51M Buy
71,540
+9,530
+15% +$840K 0.01% 869
2023
Q2
$5.02M Sell
62,010
-12,860
-17% -$1.05M 0.01% 992
2023
Q1
$5.96M Buy
74,870
+1,150
+2% +$81.5K 0.01% 924
2022
Q4
$4.99M Buy
73,720
+15,070
+26% +$884K 0.01% 962
2022
Q3
$2.92M Buy
+58,650
New +$3.14M ﹤0.01% 1173

Other funds holding NVO

VOYA Investment Management's NVO Position: Q2 2026 in Review

VOYA Investment Management increased its Novo Nordisk (NVO) stake by 14% in Q2 2026, buying an estimated $225K and bringing the position to 42,175 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1229.

VOYA Investment Management first reported a position in NVO in Q3 2022 and has held it in 16 quarters since. The position peaked at $22.6M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • VOYA Investment Management held 42,175 shares of Novo Nordisk worth $2.02M as of Q2 2026.
  • VOYA Investment Management bought 5,235 Novo Nordisk shares in Q2 2026, an estimated $225K.
  • Novo Nordisk made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1229 holding.
  • VOYA Investment Management first reported a position in Novo Nordisk in Q3 2022 and has held it in 16 quarters since.
  • VOYA Investment Management's Novo Nordisk position peaked at $22.6M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.